Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3

1 September 2025 (14:30 - 14:42)
Organised by: Logo
Congress Presentation Part of: Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology